World
Politics
Business
Investing

Home Investing RAD 202 receives approval to start Phase 1 therapeutic trial

RAD 202 receives approval to start Phase 1 therapeutic trial

by admin December 20, 2024

December 20, 2024

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Facebook Twitter Pinterest Email

previous post

Gold, Silver and Bitcoin Prices Fall as Fed Caps Off Year with Rate Cut

next post

PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx Addressing Patients with Recurrent Pericarditis

Related Posts

Juggernaut Exploration

June 14, 2025

LaFleur Minerals

June 14, 2025

Brunswick Exploration Announces AGM Results

June 14, 2025

Grande Portage Closes Non-Brokered Private Placement Pursuant to the Listed...

June 14, 2025

Crypto Market Recap: Stablecoin Market Makes Headway, SharpLink Stocks Up...

June 14, 2025

Editor’s Picks: Trump to Lift Minnesota Mining Ban, Dundee Buys...

June 14, 2025

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

Recent

Israel attacked three key Iranian nuclear facilities. Did it strike a decisive blow?

June 15, 2025
Russia is shifting tactics again, assaulting Ukrainian cities with swarms of killer drones

June 15, 2025
French president to touch down in Greenland, in solidarity with territory eyed by Trump

June 15, 2025
Israeli official vows ‘We have more surprises coming up’ for Iran following wave of airstrikes

June 15, 2025
Time for Israel to take out ‘head of the snake,’ target members of Iranian regime, says former IDF intel chief

June 15, 2025

Categories

Business (1,403)
Investing (3,452)
Politics (4,620)
World (4,527)

Email Whitelisting
Terms and Conditions
Privacy Policy
Contacts
About us

Disclaimer: EconomicRulesHub.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 EconomicRulesHub.com | All Rights Reserved

World
Politics
Business
Investing